Erratum: A genome sequencing program for novel undiagnosed diseases (Genetics in Medicine (2015) DOI: 10.1038/gim.2015.21);A genome sequencing program for novel undiagnosed diseases

Genetics in Medicine

Volumn 17, Issue 12, 2015, Pages 995-1001

  Bloss, Cinnamon S ^a   Zeeland, Ashley A Scott Van ^b   Topol, Sarah E ^a   Darst, Burcu F ^a   Boeldt, Debra L ^a   Erikson, Galina A ^a   Bethel, Kelly J ^c   Bjork, Robert L ^a   Friedman, Jennifer R ^d,e   Hwynn, Nelson ^c   Patay, Bradley A ^c   Pockros, Paul J ^c   Scott, Erick R ^a   Simon, Ronald A ^c   Williams, Gary W ^c   Schork, Nicholas J ^a,f   Topol, Eric J ^a,c,f   Torkamani, Ali ^a,b,f  

^a SCRIPPS HEALTH   (United States)

^b Cypher Genomics Inc ^*  (United States)

^c SCRIPPS CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

clinical sequencing; genome sequencing; genomics; rare disease; undiagnosed diseases

Indexed keywords

ADULT; ARTICLE; BIOINFORMATICS; CLINICAL DECISION MAKING; FEMALE; FOLLOW UP; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PATIENT REFERRAL; SCIENTIST; ADOLESCENT; CHILD; DNA SEQUENCE; GENETIC DISEASES, INBORN; GENETICS; GENOMICS; HUMAN GENOME; INFANT; MOLECULAR PATHOLOGY; PRESCHOOL CHILD; RARE DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC DISEASES, INBORN; GENOME, HUMAN; GENOMICS; HUMANS; INFANT; MALE; PATHOLOGY, MOLECULAR; RARE DISEASES; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84949234948     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.63     Document Type: Erratum

References (23)

1. Jacob HJ, Abrams K, Bick DP, et al. Genomics in clinical practice: lessons from the front lines. Sci Transl Med 2013;5:194-5.
2. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;13:255-262.
3. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014;312:1870-1879.
4. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013;369:1502-1511.
5. de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012;367: 1921-1929.
6. Srivastava S, Cohen JS, Vernon H, et al. Clinical whole exome sequencing in child neurology practice. Ann Neurol 2014;76:473-483.
7. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013;14:681-691.
8. Cooper DN, Chen JM, Ball EV, et al. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 2010;31:631-655.
9. Gahl WA, Markello TC, Toro C, et al. The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med 2012;14:51-59.
10. Robbins G. The search for what's wrong with Lilly. San Diego Union-Tribune 2013.
11. Yong E. "We gained hope." The story of Lilly Grossman's genome. National Geographic 2013.
12. Tabor HK, Berkman BE, Hull SC, Bamshad MJ. Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am J Med Genet A 2011;155A:2916-2924.
13. Mayer AN, Dimmock DP, Arca MJ, et al. A timely arrival for genomic medicine. Genet Med 2011;13:195-196.
14. Belani R, Oliveira G, Erikson GA, et al. ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma. Oncogenesis 2014;3:e111.
15. Chen YZ, Friedman JR, Chen DH, et al. Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol 2014;75:542-549.
16. Brownstein CA, Beggs AH, Homer N, et al. An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol 2014;15:R53.
17. Torkamani A, Bersell K, Jorge BS, et al. De novo KCNB1 mutations in epileptic encephalopathy. Ann Neurol 2014;76:529-540.
18. Abyzov A, Urban AE, Snyder M, Gerstein M. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res 2011;21:974-984.
19. Handsaker RE, Korn JM, Nemesh J, McCarroll SA. Discovery and genotyping of genome structural polymorphism by sequencing on a population scale. Nat Genet 2011;43:269-276.
20. Kim KS, Han PL. Mice lacking adenylyl cyclase-5 cope badly with repeated restraint stress. J Neurosci Res 2009;87:2983-2993.
21. Muona M, Berkovic SF, Dibbens LM, et al. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. Nat Genet 2015;47:39-46.
22. Harakalova M, van Harssel JJ, Terhal PA, et al. Dominant missense mutations in ABCC9 cause Cantú syndrome. Nat Genet 2012;44:793-796.
23. LaDuca H, Stuenkel AJ, Dolinsky JS, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 2014;16:830-837.